688176.SS · 亚虹医药
China A-shares · RS rating 74 · As of 2026-10-14
| Price | 12.49 CNY |
|---|---|
| 1-day change | -3.5% |
| RS rating (overall / 1M / 3M / 12M) | 74 / 53 / 51 / 81 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 32 / 36 / 10 |
| Industry group (rank) | Medical-Generic Drugs (40) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | +18.5% |
| Distance from 52-week high | +29.3% |
| Market cap (USD) | $1.1B |